Table 7.
Primary method of medicinal cannabis use among various pain syndromes, “Yes” responses on ID Migraine™ questionnaire, top non-pain related primary illnesses, and overall cohort
| Primary method of use | ||||||||
|---|---|---|---|---|---|---|---|---|
| Vaporizer | Pipe | Joint | Oral/ Edible | Waterpipe/ Bong | Juicing | Tea | Topical | |
| Headache as primary symptom (505) | 162 (32.1%) | 50 (9.9%) | 170 (33.7%) | 58 (11.5%) | 63 (12.5%) | 1 (0.2%) | 1 (0.2%) | |
| Headache as primary illness (75) | 26 (34.7%) | 8 (10.7%) | 22 (29.3%) | 9 (12%) | 8 (10.7%) | 1 (1.3%) | 1 (1.3%) | |
| Chronic pain as primary illness (598) | 179 (29.9%) | 56 (9.4%) | 183 (30.6%) | 120 (20.1%) | 56 (9.4%) | 1 (0.17%) | 3 (0.5%) | |
| Arthritis as primary illness (188) | 70 (37.2%) | 16 (8.5%) | 60 (31.9%) | 36 (19.2%) | 4 (2.1%) | 2 (1.1%) | ||
| 3 Yes (343)a | 109 (31.8%) | 37 (10.8%) | 120 (35%) | 37 (10.8%) | 39 (11.4%) | 1 (0.29%) | ||
| 2 Yes (102)b | 34 (33.3%) | 9 (8.8%) | 29 (28.4%) | 11 (10.8%) | 19 (18.6%) | |||
| 3 + 2 Yes (445) | 143 (32.1%) | 46 (10.3%) | 149 (33.5%) | 48 (10.8%) | 58 (13%) | |||
| Mental Health Condition (548) + PTSD (93) | 184 (28.7%) | 89 (13.9%) | 195 (30.4%) | 74 (11.5%) | 97 (15.1%) | 1 (0.16%) | 1 (0.16%) | |
| Insomnia/Sleep Disorder (198) | 63 (31.8%) | 19 (9.6%) | 65 (32.8%) | 30 (15.2%) | 19 (9.6%) | 1 (0.51%) | 1 (0.51%) | |
| Gastrointestinal Disorder (62) + Crohn’s Disease (35) | 34 (35.1%) | 12 (12.4%) | 26 (26.8%) | 11 (11.3%) | 14 (14.4%) | |||
| Overall Medicinal Cannabis Cohort (2032) | 632 (31.1%) | 229 (11.3%) | 617 (30.4%) | 330 (16.2%) | 212 (10.4%) | 4 (0.20%) | 2 (0.10%) | 6 (0.30%) |
a3 “Yes” responses = 97% probability of migraine
b2 “Yes” responses = 93% probability of migraine